SCHEMBL7959765

SCHEMBL7959765

NC(=O)N(O)C1CCC(c2ccc(F)cc2)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.53
SLC9A1 P19634 1/20 0.39
PARP10 Q53GL7 2/20 0.37
KDM1A O60341 2/20 0.36
KCNH2 Q12809 1/20 0.35
HRH3 Q9Y5N1 1/20 0.35
AKR1C3 P42330 1/20 0.35
AKR1C1 Q04828 1/20 0.35
SLC18A3 Q16572 1/20 0.34
SIGMAR1 Q99720 1/20 0.34
TRPV1 Q8NER1 1/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
ATM Q13315 1/20 0.33
MAP1LC3B Q9GZQ8 1/20 0.33
TACR1 P25103 1/20 0.33
DPP4 P27487 2/20 0.33
DPP8 Q6V1X1 2/20 0.33
DPP9 Q86TI2 2/20 0.33
PARP14 Q460N5 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7959762 1.00 ALOX5 (0.53) ALOX5SLC9A1PARP10KDM1AKCNH2
SCHEMBL7971120 1.00 ALOX5 (0.53) ALOX5SLC9A1PARP10KDM1AKCNH2
SCHEMBL7971122 1.00 ALOX5 (0.53) ALOX5SLC9A1PARP10KDM1AKCNH2
SCHEMBL7959763 1.00 ALOX5 (0.53) ALOX5SLC9A1PARP10KDM1AKCNH2
SCHEMBL7972814 0.89 ALOX5 (0.64) ALOX5SLC9A1PARP10KDM1AKCNH2
SCHEMBL7959777 0.89 ALOX5 (0.64) ALOX5SLC9A1PARP10KDM1AKCNH2
SCHEMBL7959780 0.89 ALOX5 (0.64) ALOX5SLC9A1PARP10KDM1AKCNH2
SCHEMBL7973210 0.85 HTR2C (0.43) ALOX5TRPV1
SCHEMBL9198851 0.85 HTR2C (0.43) ALOX5TRPV1
SCHEMBL7973201 0.85 HTR2C (0.43) ALOX5TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-5294921-A None JP disclosed
US-6291520-B1 INHIBIT THE ENZYME LIPOXYGENASE; TREATMENT OR ALLEVIATION OF INFLAMMATORY DISEASES, ALLERGIC CONDITIONS AND CARDIOVASCULAR DISEASES PFIZER 2001-09-18 US disclosed
EP-0559743-B1 NOVEL HYDROXAMIC ACID AND N-HYDROXYUREA DERIVATIVES AND THEIR USE PFIZER (US) 1995-03-08 EP disclosed
EP-0636119-A1 PHENYL SUBSTITUTED CYCLOALKYL HYDROXYUREA DERIVATIVES WHICH INHIBIT LIPOXYGENASE PFIZER INC. (US) 1995-02-01 EP disclosed
JP-H05294921-A NEW PHENYL-SUBSTITUTED CYCLOALKYLUREA DERIVATIVE AND COMPOSITION PFIZER PHARMACEUT CO LTD 1993-11-09 JP disclosed
WO-1993021149-A1 PHENYL SUBSTITUTED CYCLOALKYL HYDROXYUREA DERIVATIVES WHICH INHIBIT LIPOXYGENASE PFIZER INC. (US) 1993-10-28 WO disclosed